Application 022303
- Type
- NDA
- Sponsor
- CEPHALON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TREANDA | BENDAMUSTINE HYDROCHLORIDE | INJECTABLE; INJECTION | 100MG | Yes | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Avyxa Pharma, LLC | f359e7c6-d104-457d-a7fe-597c74440353 | 2026-05-14 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| Bendamustine Hydrochloride | BENDAMUSTINE HYDROCHLORIDE | Apotex Corp | 085dd54c-4212-d879-afef-ee52732a48c0 | 2025-09-16 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE | Azurity Pharmaceuticals, Inc. | 4df6548f-c4ad-4eb2-a54f-19766a3d90ca | 2025-04-03 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Baxter Healthcare Corporation | 766b73e2-49bb-47f9-bbb1-44cfa1a3197e | 2025-02-10 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BELRAPZO | BENDAMUSTINE HYDROCHLORIDE | Eagle Pharmaceuticals, Inc | 9759a4ae-82ca-40cf-9c02-e1cadb21cbdc | 2024-09-23 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| bendamustine hydrochloride | BENDAMUSTINE HYDROCHLORIDE | Accord Healthcare, Inc. | 33867f0f-f317-1fd0-e054-00144ff8d46c | 2024-07-18 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| bendamustine hydrochloride | BENDAMUSTINE HYDROCHLORIDE | BluePoint Laboratories | 0df025d2-c093-427a-b599-f605e71fe835 | 2024-03-29 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE | Slayback Pharma LLC | cbcc6eb7-aa62-4599-af49-05203fedb4bb | 2024-02-27 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| Bendeka | BENDAMUSTINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ace9a43b-f9bd-4896-abfe-0ef4fec67ddf | 2024-01-19 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Eugia US LLC | dbe34bc1-06b2-493f-8859-e8b143357aa8 | 2023-07-05 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | Cephalon, LLC | 39d53698-57fa-7c99-fc5b-f52a55684826 | 2022-10-27 | Warnings, Adverse reactions | TREANDA BENDAMUSTINE HYDROCHLORIDE |